Publications
- Prediction of recurrence in low and intermediate risk non-muscle invasive bladder cancer by real-time quantitative PCR analysis: cDNA microarray results2013 | First Faculty of Medicine, Second Faculty of Medicine
- Expression of BCL-2 and BAX-1 genes in the tissue of Ta, T1 urothelial carcinoma and their prognostic value2013 | First Faculty of Medicine, Second Faculty of Medicine
- Urinary Cytology and Quantitative BTA and UBC Tests in Surveillance of Patients with pTapT1 Bladder Urothelial Carcinoma2008 | First Faculty of Medicine
- Intravesical treatment of superficial bladder tumors2004 | First Faculty of Medicine
- PAX 5 and Shb expression, P53 mutation analysis and P53 expression in superficial bladder cancer2003 | First Faculty of Medicine
- Expression of PAX5, p53 immunohistochemistry and p53 mutation analysis in superficial bladder carcinoma tissuePublication without faculty affiliation
- Prognostic evaluatin of the PT1 subtype of the superficial bladder cancerPublication without faculty affiliation
- BCG treatment in superficial bladder cancer - 11 year experience in 164 patientsPublication without faculty affiliation
- Transurethral resection controlled with fluorescence cystoscopy. Prospective randomized study validating the influence on the of reccurencies of the superficial bladder cancerPublication without faculty affiliation
- Prognostic value of the semiquantitative evaluation of the expression of protein P53 in superficial bladder cancerPublication without faculty affiliation
Loading network view...